- Home
- GIB vs PODD Comparison
GIB vs PODD Comparison
Compare GIB & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIB
- PODD
- Stock Information
- Founded
- GIB 1976
- PODD 2000
- Country
- GIB Canada
- PODD United States
- Employees
- GIB N/A
- PODD N/A
- Industry
- GIB Professional Services
- PODD Medical/Dental Instruments
- Sector
- GIB Consumer Discretionary
- PODD Health Care
- Exchange
- GIB Nasdaq
- PODD Nasdaq
- Market Cap
- GIB 23.1B
- PODD 19.0B
- IPO Year
- GIB N/A
- PODD 2007
- Fundamental
- Price
- GIB $99.87
- PODD $262.61
- Analyst Decision
- GIB Buy
- PODD Buy
- Analyst Count
- GIB 4
- PODD 17
- Target Price
- GIB $156.75
- PODD $294.65
- AVG Volume (30 Days)
- GIB 295.9K
- PODD 854.2K
- Earning Date
- GIB 04-30-2025
- PODD 05-08-2025
- Dividend Yield
- GIB 0.23%
- PODD N/A
- EPS Growth
- GIB 9.08
- PODD 96.55
- EPS
- GIB 5.26
- PODD 5.78
- Revenue
- GIB $10,326,670,790.00
- PODD $2,071,600,000.00
- Revenue This Year
- GIB $10.63
- PODD $20.58
- Revenue Next Year
- GIB $5.00
- PODD $17.41
- P/E Ratio
- GIB $19.00
- PODD $45.23
- Revenue Growth
- GIB 2.83
- PODD 22.07
- 52 Week Low
- GIB $96.81
- PODD $160.19
- 52 Week High
- GIB $122.79
- PODD $289.46
- Technical
- Relative Strength Index (RSI)
- GIB 38.00
- PODD 48.11
- Support Level
- GIB $97.46
- PODD $255.76
- Resistance Level
- GIB $101.67
- PODD $276.13
- Average True Range (ATR)
- GIB 2.13
- PODD 8.32
- MACD
- GIB 0.10
- PODD 0.80
- Stochastic Oscillator
- GIB 37.18
- PODD 62.70
About GIB CGI Inc.
CGI is a Canada-based IT-services provider with an embedded position in North America and Europe. The company generates more than CAD 14 billion in annual revenue, employs over 90,000 personnel, and operates across 400 offices in 40 countries. CGI offers a broad portfolio of services such as consulting, systems integration, application maintenance, and business process services. Its largest vertical market is government, which contributes more than a third of group revenue.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it world-wide.